UNC93B1’s Role in TLR-Mediated Autoimmune Disease

Toll-like receptors (TLRs) are critical components of the immune system responsible for detecting foreign invaders. Maintaining careful control over them is essential since increased TLR signaling can potentially lead to systemic autoimmune diseases and other inflammatory conditions. A recent 2024 publication in the Journal of Experimental Medicine titled “Large-scale mutational analysis identifies UNC93B1 variants that drive TLR-mediated autoimmunity in mice and humans” delves into genetic factors contributing to TLR-driven autoimmunity.

In this study, researchers aimed to identify the mechanisms that regulate TLR function, with a particular focus on UNC93B1, a protein that interacts with TLRs. Through mutating UNC93B1, they were able to pinpoint crucial regions that change TLR activity. They then identified a family affected by cutaneous tumid lupus and juvenile idiopathic arthritis and found that they carried mutations in the same regions of UNC93B1. These mutations were found to enhance TLR responses, promoting autoimmunity and inflammation. Overall, these findings support the crucial role of UNC93B1 in controlling TLR function and demonstrate how genetic mutations in this protein can contribute to the development of autoimmune diseases.

Citation:

Rael, V. E., Yano, et al. (2024). Large-scale mutational analysis identifies UNC93B1 variants that drive TLR-mediated autoimmunity in mice and humans. The Journal of experimental medicine, 221(8), e20232005. https://doi.org/10.1084/jem.20232005